Literature DB >> 7368562

Acquired cystic transformation of the kidneys of haemodialysed patients.

B Krempien, E Ritz.   

Abstract

In the present study, the kidneys of patients who had been on maintenance haemodialysis for variable periods of time were examined at autopsy. In 21 of the 22 patients, multiple pinhead-size to pea-size, non-loculated cysts were observed both in the cortex and the medulla. In some of the cysts (4/20 patients), papillary adenomata were observed which were visible by light microscopy in 3 cases and macroscopically in 1 case. Clinical complications resulting from haemorrhage or neoplastic transformation were not observed in any of the patients of this series. Similar cysts, smaller in size and fewer in number, were also observed in kidneys of uraemic patients who had not been dialysed. Thus, the lesion does not appear to be a specific consequence of maintenance haemodialysis. It appears more likely that extensive cystic transformation of the kidneys of patients in terminal renal failure is made possible by prolonged survival on maintenance haemodialysis. The possibility of malignant transformation of the papillomata cannot be refuted, but epidemiological surveys fail to document more frequent occurrence of renal carcinoma in dialysed patients.

Entities:  

Mesh:

Year:  1980        PMID: 7368562     DOI: 10.1007/bf00427230

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  9 in total

1.  Simple renal cysts.

Authors:  S GLASER
Journal:  Br J Surg       Date:  1952-07       Impact factor: 6.939

2.  The pathogenesis of drug-induced renal cystic disease.

Authors:  F A Carone; R G Rowland; S G Perlman; C E Ganote
Journal:  Kidney Int       Date:  1974-06       Impact factor: 10.612

3.  Experimental cystic disease of the kidney. Sequential, functional, and morphologic studies.

Authors:  M Safouh; J F Crocker; R L Vernier
Journal:  Lab Invest       Date:  1970-10       Impact factor: 5.662

4.  [Obliterative intimofibrosis of the renal arteries under the influence of hemodialysis in patients with chronic renal insufficiency (author's transl)].

Authors:  H Zobl; A Schiebeler; P Ries; J Bahlmann
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975-12-31

5.  [Polyps in renal cystic disease].

Authors:  K D Gardner; A P Evan; J Bernstein
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

6.  Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis.

Authors:  M S Dunnill; P R Millard; D Oliver
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

7.  Renal cystic disease induced in newborn rats by diphenylamine derivatives.

Authors:  J F Crocker; D M Brown; R F Borch; R L Vernier
Journal:  Am J Pathol       Date:  1972-02       Impact factor: 4.307

8.  Increased incidence of malignancy during chronic renal failure.

Authors:  A J Matas; R L Simmons; C M Kjellstrand; T J Buselmeier; J S Najarian
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

9.  Increased incidence of malignancy in chronic renal failure.

Authors:  G A Sutherland; J Glass; R Gabriel
Journal:  Nephron       Date:  1977       Impact factor: 2.847

  9 in total
  4 in total

1.  Acquired cystic disease of the kidney: serious or irrelevant?

Authors:  C J Rudge
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

2.  Clinical importance of acquired cystic disease of the kidney in patients undergoing dialysis.

Authors:  P J Ratcliffe; M S Dunnill; D O Oliver
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-17

Review 3.  Epithelial hyperplasia in human polycystic kidney diseases. Its role in pathogenesis and risk of neoplasia.

Authors:  J Bernstein; A P Evan; K D Gardner
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

4.  Acquired cystic kidney disease in children undergoing long-term dialysis.

Authors:  H E Leichter; R Dietrich; I B Salusky; J Foley; A H Cohen; H Kangarloo; R N Fine
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.